EKF Diagnostics Holdings plc
EKF.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.12 | -0.49 | 0.14 | 0.51 |
| FCF Yield | 9.31% | -0.46% | 1.69% | 1.34% |
| EV / EBITDA | 9.82 | 18.47 | -100.16 | 11.87 |
| Quality | ||||
| ROIC | 8.91% | 3.56% | 10.31% | 15.85% |
| Gross Margin | 42.79% | 45.35% | 36.07% | 48.10% |
| Cash Conversion Ratio | 2.19 | 2.96 | -1.08 | 0.48 |
| Growth | ||||
| Revenue 3-Year CAGR | -9.01% | -13.69% | 0.70% | 22.14% |
| Free Cash Flow Growth | 1,818.37% | -117.20% | -15.89% | -58.89% |
| Safety | ||||
| Net Debt / EBITDA | -1.16 | -0.25 | 4.60 | -0.65 |
| Interest Coverage | 37.77 | 27.75 | 74.16 | 319.81 |
| Efficiency | ||||
| Inventory Turnover | 3.88 | 3.28 | 4.52 | 3.21 |
| Cash Conversion Cycle | 128.17 | 142.02 | 114.97 | 127.72 |